Dr. Kay on Genetic Investigations in Chronic Lymphocytic Leukemia

Neil E. Kay, MD
Published: Thursday, Aug 18, 2016



Neil E. Kay, MD, professor of medicine, Mayo Clinic, discusses the genetic investigations being conducted in chronic lymphocytic leukemia (CLL), and more specifically, monoclonal b-cell lymphocytosis (MBL), which resembles CLL but does not meet the same criteria.

Large cohorts of patients with familial CLL, who have at least one first-degree blood relative with CLL, are currently being studied in this space because their families have increased incidence of MBL.

Researchers are looking into heritable germline polymorphisms, a genetic condition that may predispose patients to MBL.

Though it appears that there is still a lot to learn about the causes of MBL, it seems that the disorder is largely genetically determined, said Kay.
SELECTED
LANGUAGE


Neil E. Kay, MD, professor of medicine, Mayo Clinic, discusses the genetic investigations being conducted in chronic lymphocytic leukemia (CLL), and more specifically, monoclonal b-cell lymphocytosis (MBL), which resembles CLL but does not meet the same criteria.

Large cohorts of patients with familial CLL, who have at least one first-degree blood relative with CLL, are currently being studied in this space because their families have increased incidence of MBL.

Researchers are looking into heritable germline polymorphisms, a genetic condition that may predispose patients to MBL.

Though it appears that there is still a lot to learn about the causes of MBL, it seems that the disorder is largely genetically determined, said Kay.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology StrategiesJul 30, 20191.0
Medical Crossfire®: Where Are We Headed in the Treatment of Triple-Negative Breast Cancer?Jul 31, 20191.5
Publication Bottom Border
Border Publication
x